Transforming Care: Reducing Hospital Admissions, Cutting Costs, and Boosting Patient Satisfaction
One year after collaborating with myLaurel, Ochsner Health reports a significant improvement.
NEW ORLEANS, April 23, 2025 /PRNewswire/ -- In March of 2024, Ochsner Health, a leading nonprofit healthcare provider in the Gulf South, announced a partnership with myLaurel, a home-based acute and transitional care company tailored to the needs of frail, elderly, and medically complex patients. The goal was to provide a better experience for patients through streamlined care delivery, ultimately improving health outcomes and reducing out-of-pocket costs.
Together, the organizations implemented myLaurel's Acute Care at Home™ program, which through timely in-home interventions and care coordination, helps to avoid low-acuity admissions from the Emergency Department (ED), reduce unnecessary hospital utilization, decrease readmission rates, and increase patient outcomes. After a full year of implementation, myLaurel and Ochsner Health confirmed the partnership's success.
"Looking back at our one year together, I'm so excited by what we've accomplished in advancing patient care and the outcomes we've delivered," says Logan Davies, MD, Medical Director of Hospital Access and Throughput at Ochsner Medical Center. "Through close integration with our hospital staff and operational system—even daily rounding with our patient teams—our teams work together to identify and enroll patients who benefit from Acute Care at Home services. Delivering in-home and transitional care in such a patient-centered way has led to significant results and positive patient outcomes, all while reducing costs for patients and enhancing overall value for the health system."
The list of impressive results from the partnership include:
30 days post discharge from ED or observation unit:
33% reduction in ED utilization
92% prevention in initial admission rates
Over 90% reduction in 15-day readmission rates
30 days post discharge from inpatient unit:*
49% reduction in readmissions
Estimated $1.8 million in value*Compared with a non-participating control group matched on medical and social acuity.
Overall Program Results
96 average patient net promoter score
90 average provider net promoter score
34% decrease in the out-of-pocket cost for patients using myLaurel
Over 3,200 bed days saved
Dr. Davies explained how saving bed days directly impacted others needing medical care. "When Ochsner patient teams can discharge eligible patients from the ED and hospital units, we can safely care for these patients at-home with myLaurel's services. By getting patients home sooner, keeping them well, and seamlessly coordinating their care we have were created over 3,200 bed days and allowed for more than 640 new admissions in our community for patients who need them most."
The Acute Care at Home program serves medically complex patients with multiple comorbidities and those with a high risk for hospital readmission. According to Dr. Marcy Carty, myLaurel's President and Chief Medical Officer, the company is highly regarded for its clinical expertise and ability to safely treat and keep patients in their homes. During the two weeks myLaurel clinicians provided at-home care for Ochsner patients, the company assumed all risk, underscoring its confidence in the program.
"Our partners and patients benefit by knowing myLaurel is committed to avoiding acute hospital utilizations," she said. "We have the diagnostics and formulary to manage new symptoms and escalations as they arise, manage treatment plans, medications, and provide patient and caregiver education."
Both companies are proud of the great start for this pilot program. Dr. Davies added "with the success of this program, we are bringing this innovative care delivery system to all seniors across Ochsner's main campus, not just those in value-based arrangements. We also hope to be a model of innovation for other healthcare systems seeking to improve hospital utilization and patient satisfaction."
The organization has plans to launch the program in several additional hospitals in 2025.
About myLaurelHeadquartered in New York, NY, myLaurel is a pioneering healthcare company dedicated to elevating patient experiences and fostering significant cost efficiencies for hospitals, health systems, ACOs, and payers along the eastern and southern coasts of the U.S. myLaurel partners with payers, health systems and providers and puts their fees at risk. myLaurel offers its unique care model to more than 100,000 covered lives. Specializing in tailored home-based care solutions, the company focuses on enhancing health outcomes for patients with frailty and complex conditions. For further details about myLaurel, visit www.mylaurelhealth.com.
About Ochsner HealthOchsner Health is the leading nonprofit healthcare provider in the Gulf South, delivering expert care at its 46 hospitals and more than 370 health and urgent care centers. For 13 consecutive years, U.S. News & World Report has recognized Ochsner as the No. 1 hospital in Louisiana. Additionally, Ochsner Children's has been recognized as the No. 1 hospital for kids in Louisiana for three consecutive years. Ochsner inspires healthier lives and stronger communities through a combination of standard-setting expertise, quality and connection not found anywhere else in the region. In 2023, Ochsner Health cared for more than 1.5 million people from every state in the nation and 65 countries. Ochsner's workforce includes more than 38,000 dedicated team members and over 4,700 employed and affiliated physicians.
Media Contact: Becky Smithbsmith@knbcomm.com 908.405.2185
View original content to download multimedia:https://www.prnewswire.com/news-releases/transforming-care-reducing-hospital-admissions-cutting-costs-and-boosting-patient-satisfaction-302435927.html
SOURCE myLaurel

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Novo Nordisk to present array of new portfolio data including studies with semaglutide and CagriSema, expanding evidence in obesity and diabetes care at ADA 2025
Full data of Phase 3 REDEFINE 1 and 2 trial results will provide insights on the potential of CagriSema Semaglutide real-world data complements evidence from previous cardiometabolic and kidney outcomes trials Data on pipeline candidate amycretin to underscore Novo Nordisk's scientific efforts to continued innovation in obesity PLAINSBORO, N.J., June 10, 2025 /PRNewswire/ -- Novo Nordisk today announced that new data from its industry-leading cardiometabolic portfolio will be showcased at the upcoming American Diabetes Association (ADA) 85th Scientific Sessions taking place in Chicago, June 20 – 23, 2025. A total of 29 abstracts will be presented, including trials investigating the efficacy and safety of CagriSema in people with overweight/obesity (REDEFINE 1) and those with overweight/obesity and type 2 diabetes (REDEFINE 2).1 Further, new data will complement the extensive body of cardiometabolic and kidney evidence for semaglutide in people with type 2 diabetes through analyses of the SOUL, STRIDE and FLOW trials, as well as insights from additional real-world studies in adults with obesity.2-4 "We recognize the complex interplay between cardiovascular and metabolic diseases, including type 2 diabetes and obesity, which require a personalized treatment approach," said Martin Holst Lange, Executive Vice President for Development at Novo Nordisk. "As we look to build an impactful portfolio of medicines to address patient needs, our data presented at ADA 2025 demonstrates not only how we are already delivering for a wide range of these needs with semaglutide, but that we are continuing to invest in innovation to support people living with serious chronic disease." The presentation of the CagriSema REDEFINE 1 and 2 trials are the first ever Phase 3 data presented on a GLP-1 and amylin receptor agonist combination, offering insights into the potential of this investigational medicine. Data will also be presented on pipeline candidate amycretin, demonstrating Novo Nordisk's scientific efforts to deliver innovation in cardiometabolic diseases and individualized healthcare solutions.1 On June 22nd, Novo Nordisk will also host an R&D investor event on our metabolic and cardiovascular health portfolio to cover the science and abstracts presented at the congress. The event will be accessible via a live webcast on the Novo Nordisk investor website. Full details of Novo Nordisk abstracts to be presented at ADA 2025. These data for medicines containing semaglutide, CagriSema, amycretin, insulin icodec, and IcoSema are investigational: ADA Scientific Sessions:
Yahoo
2 hours ago
- Yahoo
ZoomCare Opens New Clinic in Happy Valley
The company will host an Open House for the community on Jun. 13 PORTLAND, Ore., June 10, 2025 /PRNewswire/ -- ZoomCare, a network of neighborhood clinics serving a wide variety of healthcare needs, today announced the opening of a new clinic to serve the community of Happy Valley. The new clinic is located at 17155 SE Sunnyside Road, Suite #160 in the Happy Valley Crossroads Shopping Center. The clinic will be open seven days a week. Staffed with board-certified providers who cater to a broad range of illnesses and injuries, the Happy Valley clinic will also include preventive care services. The location features five exam rooms and offers on-site labs and prescriptions, allowing patients to leave with medications in hand. Since 2006, ZoomCare has been known for its patient experience, which is focused on compassion, quality, and efficiency. "ZoomCare believes you shouldn't have to travel far to receive excellent care," said Jeff Fee, Chief Executive Officer of ZoomCare. "We are thrilled to join the Happy Valley community. Opening this new location aligns perfectly with our mission to make healthcare easy and accessible for everyone." The company will celebrate the new clinic opening with an Open House event on Friday, Jun. 13, from 11 a.m. - 2 p.m. The Open House is open to the public and will offer free specialty coffee drinks and Italian sodas, fun giveaways, and a chance to meet the provider team and see the new clinic space. "This Open House is an excellent opportunity for our providers and clinic staff to get to know the people of Happy Valley," said Jennifer Alemany, Director of Clinical Operations in Portland. "We hope folks will come by, meet our team, and learn more about how ZoomCare can help with their healthcare needs now and in the future!" ZoomCare accepts Medicare and Medicare Advantage at all of its 47 locations in Oregon and Washington. Using Medicare-certified software platform Athenahealth, ZoomCare can access and share electronic health records with other providers and health systems. This certified software platform also lets ZoomCare establish partnerships with large health systems and insurance plans to increase patient access to primary, urgent, emergency, and specialty care. About ZoomCareZoomCare's vision is to make healthcare easy. Founded in 2006 in Portland, Oregon, ZoomCare operates more than 47 urgent, primary, emergency care, and specialty locations throughout Oregon and Washington. With conveniently located neighborhood clinics, plus evening and weekend hours, ZoomCare is committed to providing better access to healthcare and delivering evidence-based care with kindness at every visit. For more information, visit Follow ZoomCare on Facebook, Instagram, LinkedIn, and X. Media ContactAmanda Gibbs Director of Communications agibbs@ View original content to download multimedia: SOURCE ZoomCare
Yahoo
3 hours ago
- Yahoo
Nutrishop Co-Founder & 75-Year-Old Father Team Up for 24th Race This Father's Day
Father-daughter duo turns shared finish lines into a living testament that age is no barrier to wellness OLYMPIC VALLEY, Calif., June 10, 2025 /PRNewswire/ -- On Saturday, June 14, Nutrishop Co-Founder Tania McLendon, 51, of Incline Village, Nev., and her 75-year-old father, Anthony Nahale, of Ladera Ranch, Calif., will mark their 24th race together by taking on the Big Blue Adventures Olympic Valley 8-Miler—just one more chapter in a story that began more than a decade ago. The father-daughter duo, who often place in the top five for their age groups, crossed their first finish line in 2013 after McLendon persuaded her dad to join her for the Los Angeles New Year's Race. Since then, their racing journey has taken them from Disneyland, Kauai, and Alaska to Wyoming's Grand Tetons and Rome's Colosseum. In October, the pair will travel to Nahale's ancestral roots in Japan for the Tokyo Legacy Half Marathon. "What started as a way to share my passion for running with my dad has turned into a lifelong adventure filled with unforgettable moments," said McLendon. "Our story proves that age is not a barrier; it's never too late to start healthy habits." Building a Legacy of HealthMcLendon ran cross country in high school and later for Cal State Fullerton on a partial scholarship. Today, she still moves daily—walking or hiking 5–7 miles at Tahoe's altitude and lifting weights three times a week—but the miles shared with her dad have given her training new meaning. "The memories we've made together are priceless," she said. Nahale didn't begin running until his mid-40s. At 50, he started weekly runs on Saturdays with some friends at Dana Point Harbor. Encouraged by his daughter, he added weight training in his mid-50s. Today, he logs about 1,000 miles annually, including a mix of 5Ks, 10Ks, and half marathon races. One of Nahale's proudest and most unforgettable accomplishments so far was finishing his third marathon in Los Angeles just five days before turning 65. Another came when he and McLendon completed their first international half marathon in Rome last October. Nahale's top tips: start small, build gradually, and invest in quality shoes (he replaces his every six months). McLendon's advice: enjoy the journey, give yourself grace, and remember that consistency beats perfection, so find an approach that works for you. Fueling Their Finish LinesMcLendon credits her consistent cross-training and nutrition regimen for staying fit, healthy and injury-free. Her go-to supplements range from high-quality protein to targeted recovery blends available exclusively through On race days, she never competes without Stance Supplements Power ATP, XP2 Crossover, BCAA Complex, and XP2 Salthead Electrolyte Formula. Nahale's diet focuses on lean proteins like fish and chicken, limited sugar, whole grains, and hydration with electrolytes. He supplements daily with Forza Pro Protein, calcium, magnesium, Trailhead Collagen, and BCAA Complex, and fuels race days with energy gels and pH Labs Glumatic for recovery. A Father's Day Call to ActionWith Father's Day approaching, McLendon and Nahale hope their story inspires others to start their own wellness traditions—whether it's running, hiking, biking, cooking nutritious meals, or just spending more intentional time together. "Shared activities build memories," said Nahale. "Find your healthy adventure, whatever it is, and make it a lifelong habit." Need help starting a family fitness tradition? Visit your local Nutrishop for personalized tips and supplement guidance. About NutrishopFounded in 2003, Nutrishop has become a trusted name in health and wellness, helping individuals reach their fitness and nutrition goals. With franchisee-owned stores nationwide, the brand offers exclusive dietary supplements, body composition assessments, one-on-one support, and nutritional guidance—all backed by a low-price guarantee. Committed to exceptional customer service and community support, Nutrishop empowers customers to live healthier, happier lives. For more information, visit and follow @NutrishopUSA on Instagram. Interested in franchise opportunities? Visit to learn more. View original content to download multimedia: SOURCE Nutrishop Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data